Log In
Print
BCIQ
Print
Print this Print this
 

AT001, AT001/r84, r84

  Manage Alerts
Collapse Summary General Information
Company Affitech A/S
DescriptionHuman antibody that blocks binding of VEGF to VEGF-2
Molecular Target Vascular endothelial growth factor A (VEGF-A)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner

International Biotech Center Generium (IBC Generium); Peregrine Pharmaceuticals Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today